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Aneurysmal degeneration of the superficial femoral
artery after remote endarterectomy
Danielle B. Cameron, BA,a James H. Black III, MD,a Elliot K. Fishman, MD,b Julie A. Freischlag, MD,a
and Christopher J. Abularrage, MD,a Baltimore, Md
Superficial femoral artery reocclusion is the most common complication of remote endarterectomy with the Mollring
device. We present the first reported case of a male patient who developed aneurysmal degeneration of the superficial
femoral artery after a previous left common femoral endarterectomy and superficial femoral remote endarterectomy with
popliteal stenting. He underwent thrombolysis with subsequent percutaneous transluminal angioplasty after developing
acute left lower extremity ischemia. At 12-month follow-up, he was free of claudication symptoms. This case illustrates
the need for close surveillance and discusses possible treatment options for patients with this rare complication. (J Vasc
Surg 2012;55:1153-5.)
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5Remote endarterectomy with the Mollring device is a
less invasive method for revascularization of complete oc-
clusions of the superficial femoral artery (SFA). However,
this procedure may be complicated by reocclusion. We
present the first reported case of aneurysmal degeneration
of the SFA after common femoral endarterectomy and
superficial femoral remote endarterectomy with popliteal
stenting.
CASE REPORT
A 73-year-old male, with a past medical history of severe
coronary artery disease and atrial fibrillation requiring warfarin,
underwent a left common femoral artery endarterectomy and
remote superficial femoral artery endarterectomy (RSFAE) with
popliteal stenting at an outside institution in 2004. Of note, he had
no prior history or family history of aneurysmal disease. He was
referred to us in 2010 for aneurysmal degeneration of the SFA, at
which time he denied any symptoms of claudication. Computed
tomography scan showed a maximum diameter of 2.3 cm (Fig 1).
This was stable compared with a previous duplex ultrasound, and
he was therefore followed nonoperatively.
Later that year, he presented with acute left lower extremity
ischemia. Angiography demonstrated occlusion of the left com-
mon femoral, profunda femoris, and SFAs with reconstitution of
the below-knee popliteal artery (Fig 2). He underwent catheter-
directed thrombolysis over a period of 48 hours. Repeat angiogra-
phy demonstrated a high-grade stenosis of the left common fem-
oral artery (Fig 3). Due to his severe heart disease and the
postendarterectomy nature of this stenosis, we elected to perform
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doi:10.1016/j.jvs.2011.12.044ercutaneous transluminal angioplasty with a 6-mm balloon, fol-
owed by an 8-mmballoon. Postoperative duplex ultrasound of the
eft common femoral artery showed a peak systolic velocity (PSV)
f 214 cm/s. The left-sided ankle-brachial index (ABI) was 1.03.
e was discharged on warfarin and aspirin. At 12-month follow-
p, he was doing well without any symptoms of claudication.
is left-sided ABI was 1.06, and common femoral artery PSV
as stable at 250 cm/s. The maximum diameter of the SFA was
.3 cm.
ISCUSSION
The treatment of femoropopliteal occlusive disease has
hanged dramatically over the past 15 years. Femoropopli-
eal bypass with autogenous conduit remains the gold
tandard treatment, especially in patients with a life expec-
ancy 2 years.1 However, there is a significant increase in
orbidity and mortality associated with infrainguinal by-
ass surgery in our aging, more dependent population.2
his has led some centers to transition to an “endovascular-
rst” approach.3,4
Outcomes after open surgical revascularization depend
n lesion anatomy and conduit availability. While the
ransAtlantic Inter-Society Consensus (TASC) II working
roup recommended open bypass with autogenous con-
uit as the treatment of choice for TASC D lesions,5 the
atency of prosthetic femoropopliteal bypasses may not be
uperior to endovascular revascularization.6
In 1995, Ho et al introduced RSFAE as a less invasive
emoropopliteal revascularization procedure that was met
ith enthusiasm because it required only one small groin
ncision, preserved the saphenous vein for subsequent pe-
ipheral reconstructions or cardiac procedures, and, unlike
pen bypass, avoided implanting prosthetic material.7 This
rocedure could be combined with open common femoral
ndarterectomy, and early studies found reduced length of
tay and comparable assisted patency compared with open
ypass.8,9
A systematic review of the 19 nonrandomized case
eries of RSFAE found primary patency rates of 77% and
7% at 2 and 5 years, respectively.10 Recurrent stenoses
ccurred in almost 50% of patients, the majority within the
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veillance and early revision of recurrent stenoses is manda-
tory and can lead to assisted-primary patency rates of 77%
Fig 1. Computed tomography angiogram (A) of the abdomen,
pelvis, and lower extremities reveals aneurysmal degeneration of
the left superficial femoral artery (SFA) status post common fem-
oral endarterectomy, superficial femoral remote endarterectomy,
and popliteal stenting (arrows). Note the preserved runoff only
seen on delayed imaging (B).
Fig 2. Initial pelvic angiogram showing complete occlusion of
the left common femoral artery, profunda femoris artery, and
superficial femoral artery (SFA).and 50% at 2 and 5 years, respectively.10,12 However, oalland et al showed that the cost of maintaining patency
ollowing RSFAE was nearly five times the cost of the same
or in situ bypass.13 With that taken into consideration, the
educed cost of shorter hospital stay associated with this less
nvasive repair is offset by the costly efforts to maintain
atency postoperatively.
While restenosis of the SFA is the most common com-
lication after RSFAE, there are no reports in the literature
o date of aneurysmal degeneration of the SFA and thus no
vailable guidelines for treatment. We present this case to
ighlight this unusual complication and describe our man-
gement. The most likely etiology of aneurysmal degener-
tion in this patient is that the endarterectomy plane at the
ime of the original surgery was too thin, leading to subse-
uent degeneration. It is impossible to confirm this, how-
ver, because pathology slides were unavailable. A genetic
neurysmal predisposition is less likely, as the patient had
o past medical or family history of aneurysmal disease.
Initially, we chose to follow the patient because he was
symptomatic, and computed tomography scan demon-
trated that the aneurysm was stable in size. In the presence
f an expanding aneurysm, surgical intervention should be
ndicated. Given significant cardiopulmonary comorbidity
nd lack of suitable autologous vein due to coronary bypass,
conservative posture was taken on repair of the extensive
neurysm. Other treatment options include femoropopli-
eal bypass or covered stenting. While we did consider
ndovascular covered stenting of the SFA aneurysm, this
as a technically poor option for two reasons. First, there
as an inadequate proximal seal zone. Second, in order to
ig 3. Postthrombolysis angiography (A) showing wide patency
f the left external iliac and profunda femoris arteries, with a
igh-grade stenosis of the common femoral artery (arrow). Post-
ngioplasty image (B) shows a widely patent common femoral
rtery. The superficial femoral artery (SFA) is patent and aneurys-
al.btain an adequate distal seal zone, we would have had to
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thus increasing the risk of stent thrombosis secondary to
knee joint flexion.
When the patient presented later that year with acute
ischemia, it was unclear if the cause was thromboembolism
of the SFA aneurysm, thrombosis of the popliteal stent, or
restenosis of the common femoral artery. Based on the fact
that blood flow was not preserved through the common
femoral and profunda femoris arteries, restenosis of the
common femoral artery seemed the most likely. This was
confirmed on postthrombolysis angiography. And while
common femoral angioplasty is controversial as a primary
treatment, it is associated with acceptable limb salvage
rates, especially with preserved runoff.14
In conclusion, this is the first reported case of SFA
aneurysmal degeneration after RSFAE. Close follow-up is
mandatory because the risk of distal thromboembolism,
and less likely aneurysm rupture, is undefined.
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